Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007354

Director acquired 2,058 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Geoffrey E. Director 2016-09-21 Option exercise +2,058 $5.00 $10,290 4,558 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harris Geoffrey E. Director 2016-09-21 Option exercise · 5% Secured Convertible Note due December 2017 −0 D: show line 2 in the form
Harris Geoffrey E. Director 2016-09-21 Returned to the company · Common Stock Warrant −0 0 D: show line 3 in the form
Loading xslF345X03/s104196_form4.xml…